際際滷shows by User: jmartinezclark / http://www.slideshare.net/images/logo.gif 際際滷shows by User: jmartinezclark / Fri, 30 Mar 2018 16:02:53 GMT 際際滷Share feed for 際際滷shows by User: jmartinezclark Colombia INVIMA medical device registration document requirements /slideshow/colombia-medical-device-registration-document-requirements-march-6-2018/92411162 colombiamedicaldeviceregistrationdocumentrequirementsmarch62018-180330160253
Commercial medical devices in Colombia require registration with INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos), the countrys medical device regulator. Classification of devices in Colombia follows a four-tiered risk model (Class I, Class IIa, Class IIb and Class III). Colombias device classification system is similar to those of the European Union and other Global Harmonization Task Force (GHTF) systems. If the device falls into a lower-risk category in Colombia (Class I or IIa), the company will qualify for an automatic certificate upon notification to INVIMA it will be able to sell its devices immediately. ]]>
Commercial medical devices in Colombia require registration with INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos), the countrys medical device regulator. Classification of devices in Colombia follows a four-tiered risk model (Class I, Class IIa, Class IIb and Class III). Colombias device classification system is similar to those of the European Union and other Global Harmonization Task Force (GHTF) systems. If the device falls into a lower-risk category in Colombia (Class I or IIa), the company will qualify for an automatic certificate upon notification to INVIMA it will be able to sell its devices immediately. ]]> Fri, 30 Mar 2018 16:02:53 GMT /slideshow/colombia-medical-device-registration-document-requirements-march-6-2018/92411162 jmartinezclark@slideshare.net(jmartinezclark) Colombia INVIMA medical device registration document requirements jmartinezclark Commercial medical devices in Colombia require registration with INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos), the countrys medical device regulator. Classification of devices in Colombia follows a four-tiered risk model (Class I, Class IIa, Class IIb and Class III). Colombias device classification system is similar to those of the European Union and other Global Harmonization Task Force (GHTF) systems. If the device falls into a lower-risk category in Colombia (Class I or IIa), the company will qualify for an automatic certificate upon notification to INVIMA it will be able to sell its devices immediately. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/colombiamedicaldeviceregistrationdocumentrequirementsmarch62018-180330160253-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Commercial medical devices in Colombia require registration with INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos), the countrys medical device regulator. Classification of devices in Colombia follows a four-tiered risk model (Class I, Class IIa, Class IIb and Class III). Colombias device classification system is similar to those of the European Union and other Global Harmonization Task Force (GHTF) systems. If the device falls into a lower-risk category in Colombia (Class I or IIa), the company will qualify for an automatic certificate upon notification to INVIMA it will be able to sell its devices immediately.
Colombia INVIMA medical device registration document requirements from Julio G. Martinez-Clark
]]> 3632 2 https://cdn.slidesharecdn.com/ss_thumbnails/colombiamedicaldeviceregistrationdocumentrequirementsmarch62018-180330160253-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Foreign clinical trials (FCTs) for life science startups /slideshow/foreign-clinical-trials-fcts-for-life-science-startups/66739256 foreignclinicaltrialsfctsforlifesciencestartups-161004213628
Did you know 40-65% of all clinical trials involving FDA-regulated products are being conducted overseas? Time, reduced costs, and easier subject recruitment are the factors that make life science companies to conduct clinical trials overseas. ]]>
Did you know 40-65% of all clinical trials involving FDA-regulated products are being conducted overseas? Time, reduced costs, and easier subject recruitment are the factors that make life science companies to conduct clinical trials overseas. ]]> Tue, 04 Oct 2016 21:36:28 GMT /slideshow/foreign-clinical-trials-fcts-for-life-science-startups/66739256 jmartinezclark@slideshare.net(jmartinezclark) Foreign clinical trials (FCTs) for life science startups jmartinezclark Did you know 40-65% of all clinical trials involving FDA-regulated products are being conducted overseas? Time, reduced costs, and easier subject recruitment are the factors that make life science companies to conduct clinical trials overseas. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/foreignclinicaltrialsfctsforlifesciencestartups-161004213628-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Did you know 40-65% of all clinical trials involving FDA-regulated products are being conducted overseas? Time, reduced costs, and easier subject recruitment are the factors that make life science companies to conduct clinical trials overseas.
Foreign clinical trials (FCTs) for life science startups from Julio G. Martinez-Clark
]]> 5763 9 https://cdn.slidesharecdn.com/ss_thumbnails/foreignclinicaltrialsfctsforlifesciencestartups-161004213628-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 I.P.S. en Colombia: Aumente sus ingresos y su nivel cient鱈fico. https://es.slideshare.net/slideshow/ips-en-colombia-oportunidad-de-exportacion-de-servicios-y-realizacion-de-proyectos-internacionales-de-investigacion-clinica-en-humanos-con-tecnologias-innovadoras-en-ciencias-de-la-vida/59425138 i-160311142546
Aumente y diversifique sus ingresos. Obtenga reconocimiento acad辿mico internacional. Exporte servicios de salud al servicio de la industria global farmace炭tica y de innovaci坦n en ciencias de la salud por medio de investigaci坦n cl鱈nica en humanos.]]>
Aumente y diversifique sus ingresos. Obtenga reconocimiento acad辿mico internacional. Exporte servicios de salud al servicio de la industria global farmace炭tica y de innovaci坦n en ciencias de la salud por medio de investigaci坦n cl鱈nica en humanos.]]> Fri, 11 Mar 2016 14:25:46 GMT https://es.slideshare.net/slideshow/ips-en-colombia-oportunidad-de-exportacion-de-servicios-y-realizacion-de-proyectos-internacionales-de-investigacion-clinica-en-humanos-con-tecnologias-innovadoras-en-ciencias-de-la-vida/59425138 jmartinezclark@slideshare.net(jmartinezclark) I.P.S. en Colombia: Aumente sus ingresos y su nivel cient鱈fico. jmartinezclark Aumente y diversifique sus ingresos. Obtenga reconocimiento acad辿mico internacional. Exporte servicios de salud al servicio de la industria global farmace炭tica y de innovaci坦n en ciencias de la salud por medio de investigaci坦n cl鱈nica en humanos. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/i-160311142546-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Aumente y diversifique sus ingresos. Obtenga reconocimiento acad辿mico internacional. Exporte servicios de salud al servicio de la industria global farmace炭tica y de innovaci坦n en ciencias de la salud por medio de investigaci坦n cl鱈nica en humanos.
from Julio G. Martinez-Clark
]]> 2918 7 https://cdn.slidesharecdn.com/ss_thumbnails/i-160311142546-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Miami MedTech Innovation Center - Presentation /slideshow/miami-medtech-innovation-center-presentation/55440612 miamimedtechpresentation1123-1-151123235031-lva1-app6892
Take your Idea. Develop your Product. Test it, Sell it, and Exit. Innovative clinical minds face difficulties actualizing great product ideas because of the complexities associated with healthcare product development. A successful healthcare innovation development process involves integrating many complex disciplines at the highest level of quality in order to provide patients with the safest and most effective treatment options. As a result, many innovators never begin to develop their ideas because of intimidation or lack of resources. Some innovators go through the stressful and costly undertaking of an improvised development process that ultimately leads to a less than optimum product and poor financial returns. In order to solve this problem, we created a comprehensive platform to efficiently translate ideas into effective and successful healthcare products.]]>
Take your Idea. Develop your Product. Test it, Sell it, and Exit. Innovative clinical minds face difficulties actualizing great product ideas because of the complexities associated with healthcare product development. A successful healthcare innovation development process involves integrating many complex disciplines at the highest level of quality in order to provide patients with the safest and most effective treatment options. As a result, many innovators never begin to develop their ideas because of intimidation or lack of resources. Some innovators go through the stressful and costly undertaking of an improvised development process that ultimately leads to a less than optimum product and poor financial returns. In order to solve this problem, we created a comprehensive platform to efficiently translate ideas into effective and successful healthcare products.]]> Mon, 23 Nov 2015 23:50:31 GMT /slideshow/miami-medtech-innovation-center-presentation/55440612 jmartinezclark@slideshare.net(jmartinezclark) Miami MedTech Innovation Center - Presentation jmartinezclark Take your Idea. Develop your Product. Test it, Sell it, and Exit. Innovative clinical minds face difficulties actualizing great product ideas because of the complexities associated with healthcare product development. A successful healthcare innovation development process involves integrating many complex disciplines at the highest level of quality in order to provide patients with the safest and most effective treatment options. As a result, many innovators never begin to develop their ideas because of intimidation or lack of resources. Some innovators go through the stressful and costly undertaking of an improvised development process that ultimately leads to a less than optimum product and poor financial returns. In order to solve this problem, we created a comprehensive platform to efficiently translate ideas into effective and successful healthcare products. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/miamimedtechpresentation1123-1-151123235031-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Take your Idea. Develop your Product. Test it, Sell it, and Exit. Innovative clinical minds face difficulties actualizing great product ideas because of the complexities associated with healthcare product development. A successful healthcare innovation development process involves integrating many complex disciplines at the highest level of quality in order to provide patients with the safest and most effective treatment options. As a result, many innovators never begin to develop their ideas because of intimidation or lack of resources. Some innovators go through the stressful and costly undertaking of an improvised development process that ultimately leads to a less than optimum product and poor financial returns. In order to solve this problem, we created a comprehensive platform to efficiently translate ideas into effective and successful healthcare products.
Miami MedTech Innovation Center - Presentation from Julio G. Martinez-Clark
]]> 8644 8 https://cdn.slidesharecdn.com/ss_thumbnails/miamimedtechpresentation1123-1-151123235031-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Shorten trial startup. Lower your costs. Recruit more patients, faster. All in Colombia! /slideshow/shorten-trial-startup-lower-your-costs-recruit-more-patients-faster-all-in-colombia/53783971 colombia-atopdestinationforclinicaltrials-151011022401-lva1-app6892
Colombia offers unparalleled benefits to pharma, medtech & biotech startups looking for a place to conduct their clinical trials with fast regulatory approval, ample access to patients, and very competitive costs. ]]>
Colombia offers unparalleled benefits to pharma, medtech & biotech startups looking for a place to conduct their clinical trials with fast regulatory approval, ample access to patients, and very competitive costs. ]]> Sun, 11 Oct 2015 02:24:01 GMT /slideshow/shorten-trial-startup-lower-your-costs-recruit-more-patients-faster-all-in-colombia/53783971 jmartinezclark@slideshare.net(jmartinezclark) Shorten trial startup. Lower your costs. Recruit more patients, faster. All in Colombia! jmartinezclark Colombia offers unparalleled benefits to pharma, medtech & biotech startups looking for a place to conduct their clinical trials with fast regulatory approval, ample access to patients, and very competitive costs. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/colombia-atopdestinationforclinicaltrials-151011022401-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Colombia offers unparalleled benefits to pharma, medtech &amp; biotech startups looking for a place to conduct their clinical trials with fast regulatory approval, ample access to patients, and very competitive costs.
Shorten trial startup. Lower your costs. Recruit more patients, faster. All in Colombia! from Julio G. Martinez-Clark
]]> 493 6 https://cdn.slidesharecdn.com/ss_thumbnails/colombia-atopdestinationforclinicaltrials-151011022401-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Innovaci坦n M辿dica e Investigaci坦n Cl鱈nica en Colombia: Una oportunidad para exportar USD $2 mil millones en el 2020 /slideshow/investigacin-clnica-en-colombia-una-oportunidad-para-exportar-usd-2-mil-millones-en-el-2020/53783915 colombia-elmejordestinoparainvestigacionclinicaoct72015-151011021923-lva1-app6891
Los estudios cl鱈nicos son un importante aspecto para el desarrollo de la innovaci坦n m辿dica mundial. Estos generan empleo y contribuyen significativamente a la econom鱈a nacional. Tambi辿n generan nuevos conocimientos, innovaci坦n, y ayudan a traducir ese conocimiento en mejores maneras para tratar enfermedades y para mejorar la salud p炭blica de la poblaci坦n. Es claro que un ecosistema que facilite y atraiga la inversi坦n en estudios cl鱈nicos contribuir叩 al mejoramiento de la salud, el aumento de la riqueza de la naci坦n y a un crecimiento econ坦mico duradero. Colombia tiene el potencial de aumentar el tama単o de esta industria a aproximadamente USD $2 mil millones al 2020, esto equivale a un incremento de su participaci坦n del 0.4% al 3% del tama単o global de la industria de investigaci坦n cl鱈nica (USD $64 mil millones).]]>
Los estudios cl鱈nicos son un importante aspecto para el desarrollo de la innovaci坦n m辿dica mundial. Estos generan empleo y contribuyen significativamente a la econom鱈a nacional. Tambi辿n generan nuevos conocimientos, innovaci坦n, y ayudan a traducir ese conocimiento en mejores maneras para tratar enfermedades y para mejorar la salud p炭blica de la poblaci坦n. Es claro que un ecosistema que facilite y atraiga la inversi坦n en estudios cl鱈nicos contribuir叩 al mejoramiento de la salud, el aumento de la riqueza de la naci坦n y a un crecimiento econ坦mico duradero. Colombia tiene el potencial de aumentar el tama単o de esta industria a aproximadamente USD $2 mil millones al 2020, esto equivale a un incremento de su participaci坦n del 0.4% al 3% del tama単o global de la industria de investigaci坦n cl鱈nica (USD $64 mil millones).]]> Sun, 11 Oct 2015 02:19:23 GMT /slideshow/investigacin-clnica-en-colombia-una-oportunidad-para-exportar-usd-2-mil-millones-en-el-2020/53783915 jmartinezclark@slideshare.net(jmartinezclark) Innovaci坦n M辿dica e Investigaci坦n Cl鱈nica en Colombia: Una oportunidad para exportar USD $2 mil millones en el 2020 jmartinezclark Los estudios cl鱈nicos son un importante aspecto para el desarrollo de la innovaci坦n m辿dica mundial. Estos generan empleo y contribuyen significativamente a la econom鱈a nacional. Tambi辿n generan nuevos conocimientos, innovaci坦n, y ayudan a traducir ese conocimiento en mejores maneras para tratar enfermedades y para mejorar la salud p炭blica de la poblaci坦n. Es claro que un ecosistema que facilite y atraiga la inversi坦n en estudios cl鱈nicos contribuir叩 al mejoramiento de la salud, el aumento de la riqueza de la naci坦n y a un crecimiento econ坦mico duradero. Colombia tiene el potencial de aumentar el tama単o de esta industria a aproximadamente USD $2 mil millones al 2020, esto equivale a un incremento de su participaci坦n del 0.4% al 3% del tama単o global de la industria de investigaci坦n cl鱈nica (USD $64 mil millones). <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/colombia-elmejordestinoparainvestigacionclinicaoct72015-151011021923-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Los estudios cl鱈nicos son un importante aspecto para el desarrollo de la innovaci坦n m辿dica mundial. Estos generan empleo y contribuyen significativamente a la econom鱈a nacional. Tambi辿n generan nuevos conocimientos, innovaci坦n, y ayudan a traducir ese conocimiento en mejores maneras para tratar enfermedades y para mejorar la salud p炭blica de la poblaci坦n. Es claro que un ecosistema que facilite y atraiga la inversi坦n en estudios cl鱈nicos contribuir叩 al mejoramiento de la salud, el aumento de la riqueza de la naci坦n y a un crecimiento econ坦mico duradero. Colombia tiene el potencial de aumentar el tama単o de esta industria a aproximadamente USD $2 mil millones al 2020, esto equivale a un incremento de su participaci坦n del 0.4% al 3% del tama単o global de la industria de investigaci坦n cl鱈nica (USD $64 mil millones).
Innovacin M莨dica e Investigacin Cl蕷nica en Colombia: Una oportunidad para exportar USD $2 mil millones en el 2020 from Julio G. Martinez-Clark
]]> 324 7 https://cdn.slidesharecdn.com/ss_thumbnails/colombia-elmejordestinoparainvestigacionclinicaoct72015-151011021923-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-jmartinezclark-48x48.jpg?cb=1582793727 WHAT WE DO: We help life science companies effectively enter the market and achieve long-term growth in Latin America/Colombia. We do this by offering a wide range of market access services including regulatory product registration, legal representation, distributor search, trademark registration, and other services to enable them to expand their market and increase sales. WHO WE WORK WITH: We work with life science companies looking to expand their market in Latin America. Companies such as CeloNova, ClarVista, Sanuwave, Medimaps, and others, have trusted our services in Colombia. WHY IT WORKS: By partnering with us, you will have a team of US and Latin American experts helping you ... www.interventionalconcepts.net https://cdn.slidesharecdn.com/ss_thumbnails/colombiamedicaldeviceregistrationdocumentrequirementsmarch62018-180330160253-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/colombia-medical-device-registration-document-requirements-march-6-2018/92411162 Colombia INVIMA medica... https://cdn.slidesharecdn.com/ss_thumbnails/foreignclinicaltrialsfctsforlifesciencestartups-161004213628-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/foreign-clinical-trials-fcts-for-life-science-startups/66739256 Foreign clinical trial... https://cdn.slidesharecdn.com/ss_thumbnails/i-160311142546-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/ips-en-colombia-oportunidad-de-exportacion-de-servicios-y-realizacion-de-proyectos-internacionales-de-investigacion-clinica-en-humanos-con-tecnologias-innovadoras-en-ciencias-de-la-vida/59425138 I.P.S. en Colombia: Au...